RecruitingNCT04677998

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

1,000 participants

Start Date

Nov 24, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine the efficacy and safety of a personalized surveillance and intervention protocol for duodenal and gastric polyposis in patients with familial adenomatous polyposis (FAP)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is creating a personalized monitoring and treatment protocol for patients with Familial Adenomatous Polyposis (FAP) — a hereditary condition causing many polyps (pre-cancerous growths) throughout the digestive system, including the stomach and small intestine (duodenum). Researchers want to improve how these at-risk patients are watched over time to prevent cancer from developing. **You may be eligible if you:** - Have been diagnosed with FAP, confirmed either by genetic testing (APC gene mutation) or by clinical diagnosis (100+ colorectal polyps with a family history of FAP) - Are 18 years of age or older - Have not yet developed stomach or duodenal (small intestine) cancer - Do not require surgery at this time **You may NOT be eligible if you:** - Have cancer detected in your stomach or small intestine at baseline endoscopy - Cannot have all polyps removed endoscopically - Require surgery now Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPersonalized surveillance and intervention protocol

This study uses one arm. Participants will undergo endoscopic surveillance with intervals between 3-6 months and 5 years, depending on severity of polyposis and performed endoscopic interventions.


Locations(2)

MD Anderson

Houston, Texas, United States

Academic Medical Centre

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04677998


Related Trials